The value of EEG monitoring after cardiac arrest treated with hypothermia
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The prognostic value of EEG in comatose patients after cardiac arrest (CA) has been an important clinical issue for decades. Research started in the 1960s with the classic study by Hockaday et al.1 in which EEG predicted outcome with a not-so-great reliability of about 80%. At present, the management of post-CA patients often involves the induction of therapeutic hypothermia (TH). TH, a neuroprotective strategy, improves clinical outcomes in comatose patients after witnessed out-of-hospital CA from ventricular fibrillation in randomized controlled trials,2 and it is standard of care for these patients. How to prognosticate outcome in post-CA patients treated with hypothermia has become a very active area of research, in particular regarding the value of EEG monitoring. In this issue of Neurology®, Rossetti et al.3 add valuable information to this growing body of literature.
Rossetti et al. evaluated the prognostic value of EEG findings during TH. They used elevated serum levels of neuron-specific enolase (NSE) as a surrogate marker of irreversible brain damage. They hypothesized that “malignant” EEG patterns were indicative of neuronal damage or death and sought support for this idea by correlating EEG with high NSE levels. The results of their study confirm …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.